Device Trial Radar · NCT02991313
Evaluation of a Multi-electrode Linear Type Catheter (D-1368-01-SI)
Last checked: Nov 20, 2026Latest source record: Feb 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Planned (sponsor's estimate)
Start
Oct 1, 2016
Primary completion
Nov 30, 2018
Study completion Nov 30, 2018
Sponsor
- Lead sponsor
- Biosense Webster, Inc.Public (JNJ)
- Sponsor type
- Industry
- First posted
- Dec 13, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this trial is to assess acute safety and performance of the Multi-electrode Linear Type Catheter in conjunction with generator software V2.4.0 or above when used for the treatment of Persistent Atrial Fibrillation.
Conditions
- Persistent Atrial Fibrillation
Interventions
Endocardial Ablation ProcedureDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Early Onset of Primary Adverse EventsTime frame: Within 7 days
- Confirmation of entrance blockTime frame: Intraoperative
- Confirmation of bi-directional blockTime frame: Intraoperative
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.